Genetics of chloroquine-resistant malaria: A haplotypic view

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 8, 2013, Pages 947-961

  Awasthi, Gauri ^a   Das, Aparup ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Chloroquine; Evolution; Haplotypes; Malaria; Pfcrt gene

Indexed keywords

ANTIMALARIAL AGENT; CARRIER PROTEIN; CHLOROQUINE; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL DNA; PROTOZOAL PROTEIN;

DRUG EFFECTS; DRUG RESISTANCE; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; HUMAN; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; CHLOROQUINE; DNA, PROTOZOAN; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS;

EID: 84890353889     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276130274     Document Type: Review

References (181)

1. Adagut IS, Warhurst DC 2001. Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123: 219-224.
2. Al-Hamidhi S, Mahdy MA, Al-Hashami Z, Al-Farsi H, Al-Mekhlafi AM, Idris MA, Beja-Pereira A, Babiker HA 2013. Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen. Malar J 12: 244.
3. Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, Enevold A, Rønn AM, Khalil IF, Warhurst DC, Lemnge MM, Theander TG, Bygbjerg IC 2006. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falcipa-rum in Tanzania. J Infect Dis 193: 1738-1741.
4. Almeida AD, Arez AP, Cravo PVL, do Rosário VE 2009. Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor. Malar J 8: 59.
5. Anderson TJ 2009. Mapping the spread of malaria drug resistance. PLoS Med 6: e1000054.
6. Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, Nosten F 2005. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother 49: 2180-2188.
7. Anderson TJ, Roper C 2005. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop 94: 269-280.
8. Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, Ekala MT, Bouchier C, Cojean S, Duchemin JB, Robert V, Le Bras J, Mercereau-Puijalon O 2006. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J 5: 34.
9. Awasthi G, Prasad GB, Das A 2011. Population genetic analyses of Pfcrt haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India. Int J Parasitol 41: 705-709.
10. Awasthi G, Satya GBK, Das A 2012. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz 107: 129-134.
11. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D 2001. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr 1. J Infect Dis 183: 1535-1538.
12. Baird JK, Nalim MFS, Basri H, Masbar S, Leksana B, Tjitra E, Dewi RM, Khairani M, Wignall FS 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans R Soc Trop Med Hyg 90: 409-411.
13. Basco LK, Ringwald P 1999. Chloroquine resistance in Plasmodium falciparum and polymorphism of the cg2 gene. J Infect Dis 180: 1979-1986.
14. Basco LK, Ringwald P 2001. Point mutations in the Plasmodium falciparum cg2 gene, polymorphism of the kappa repeat region and their relationship with chloroquine resistance. Trans R Soc Trop Med Hyg 95: 309-314.
15. Bennett TN, Kosar AD, Ursos LM, Dzekunov S, Sidhu ABS, Fidock DA, Roepe PD 2004. Drug resistance-associated PfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol Biochem Parasitol 133: 99-114.
16. Bharti PK, Alam MT, Boxer R, Shukla MM, Gautam SP, Sharma YD, Singh N 2009. Therapeutic efficacy of chloroquine and sequence variation in Pfcrt gene among patients with falciparum malaria in central India. Trop Med Int Health 15: 3340.
17. Bloland PB 2001. Drug resistance in malaria, WHO/CDS/CRS/DRS, Geneva, 32 pp.
18. Bob NS, Diop BM, Renaud F, Marrama L, Durand P, Tall A, Ka B, Ekala MT, Bouchier C, Mercereau-Puijalon O, Jambou R 2010. Parasite polymorphism and severe malaria in dakar (Senegal): a west African urban area. PLoS ONE 23: 5.
19. Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA 2005. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol 56: 323-333.
20. Chaijaroenkul W, Ward SA, Mungthin M, Johnson D, Owen A, Bray PG, Na-Bangchang K 2011. Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum. Malar J 10: 42.
21. Chan CW, Spathis R, Reiff DM, McGrath SE, Garruto RM, Lum JK 2012. Diversity of Plasmodium falciparum chloroquine resistance transporter (pfcrt) exon 2 haplotypes in the Pacific from 1959 to 1979. PLoS ONE 7: e30213.
22. Chen N, Kyle DE, Pasay C 2003. Pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother 47: 3500-3505.
23. Clark AG 2002. Malaria variorum. Nature 418: 283-285.
24. Coatney GR 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg 12: 121-128.
25. Contreras CE, Cortese JF, Caraballo A, Plowe CV 2002. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am J Trop Med Hyg 67: 400-405.
26. Cooper RA, Ferdig MT, Su XZ, Ursos LM, Mu J, Nomura T, Fujioka H, Fidock DA, Roepe PD, Wellems TE 2002. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 61: 35-42.
27. Cooper RA, Hartwig CL, Ferdig MT 2005. Pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop 94: 170-180.
28. Cortese JF, Caraballo A, Contreras CE, Plowe CV 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186: 999-1006.
29. Cowman AF, Galatis D, Thompson JK 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr 1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
30. DaRe JT, Mehlotra RK, Michon P, Mueller I, Reeder J, Sharma YD, Stoneking M, Zimmerman PA 2007. Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. Malar J 6: 34.
31. Das A, Dash AP 2007. Evolutionary paradigm of chloroquine-resistant malaria in India. Trends Parasitol 23: 132-135.
32. Dittrich S, Alifrangis M, Stohrer JM, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, Phompida S, Khalil IF, Jelinek T 2005. Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health 10: 1267-1270.
33. Djimde AA, Barger B, Kone A, Beavogui AH, Tekete M, Fofana B, Dara A, Maiga H, Dembele D, Toure S, Dama S, Ouologuem D, Sangare CP, Dolo A, Sogoba N, Nimaga K, Kone Y, Doumbo OK 2010. A molecular map of chloroquine resistance in Mali. FEMS Immunol Med Microbiol 58: 113-118.
34. Djimde AA, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV 2001. A molecular marker for chloroquine resistant falciparum malaria. N Engl J Med 344: 257-263.
35. Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69: 558-563.
36. Duraisingh MT, Cowman AF 2005. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181-190.
37. Duraisingh MT, Refour P 2005. Multiple drug resistance genes in malaria-from epistasis to epidemiology. Mol Microbiol 54: 874-877.
38. Duraisingh MT, von Seidlein LV, Jepson A, Jones P, Sambou I, Pinder M, Warhurst DC 2000. Linkage disequilibrium between two chromosomally distinct loci associated with increased resistance to chloroquine in Plasmodium falciparum. Parasitology 121: 1-7.
39. Durand R, Gabbett E, Di Piazza JP, Delabre JF, Le Bras J 1999. Analysis of κ and ω repeats of the cg2 gene and chloroquine susceptibility in isolates of Plasmodium falciparum from sub-Saharan Africa. Mol Biochem Parasitol 101: 185-197.
40. Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic Z, Le Bras J 2001. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol 114: 95-102.
41. Durand V, Berry A, Sem R, Glaziou P, Beaudou J, Fandeur T 2004. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol Biochem Parasitol 136: 273-285.
42. Dzekunov SM, Ursos LM, Roepe PD 2000. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol 110: 107-124.
43. Echeverry DF, Holmgren G, Murillo C 2007. Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am J Trop Med Hyg 77: 1034-1038.
44. Ecker A, Lehane AM, Clain J, Fidock DA 2012. PfCRT and its role in antimalarial drug resistance. Trends Parasitol 28: 504-514.
45. Ekland EH, Fidock DA 2007. Advances in understanding the genetic basis of antimalarial drug resistance. Curr Opin Microbiol 10: 363-370.
46. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, Wellems TE 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 52: 985-997.
47. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su X-z, Wootton JC, Roepe PD, Wellems TE 2000. Mutations in the P. falcipa-rum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
48. Fitch CD 2004. Ferriprotoporphyrin IX, phospholipids and the antimalarial actions of quinoline drugs. Life Sci 74: 1957-1972.
49. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
50. Fowler EV, Chavchich M, Chen N, Peters JM, Kyle DE, Gatton ML, Cheng Q 2006. Physical linkage to drug resistance genes results in conservation of var genes among west pacific Plasmodium falciparum isolates. J Infect Dis 194: 939-948.
51. Gadalla NB, Elzaki SE, Mukhtar S, Warhurst DC, El-Sayed B, Sutherland CJ 2010. Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malar J 9: 74.
52. Gama BE, Lacerda MVG, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2011. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control. Mem Inst Oswaldo Cruz 106 (Suppl. I): 159-166.
53. Gama BE, Pereira-Carvalho GAL, Kosi FJIL, de Oliveira NKA, Fortes F, Rosenthal PJ, Daniel-Ribeiro CT, Ferreira-da-Cruz MF 2010. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malar J 9: 174.
54. Ginsburg H, Famin O, Zhang J, Krugliak M 1998. Inhibition of glutathione dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 56: 1305-1313.
55. Ginsburg H, Golenser J 2003. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep 8: 276-279.
56. Greenhouse B, Slater M, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Clark TD, Staedke SG, Kamya MR, Hubbard A, Rosenthal PJ, Dorsey G 2009. Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. J Infect Dis 199: 758-765.
57. Griffing S, Syphard L, Sridaran S, McCollum AM, Mixson-Hayden T, Vinayak S, Villegas L, Barnwell JW, Escalante AA, Udhayakumar V 2010. Pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother 54: 1572-1579.
58. Gupta B, Awasthi G, Das A 2010. Malaria parasite genome scan: insights into antimalarial resistance. Parasitol Res 107: 495-499.
59. Hastings IM 1997. A model for the origins and spread of drug resistant malaria. Parasitology 115: 133-141.
60. Hastings IM, D'Alessandro U 2000. Modeling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol Today 16: 340-347.
61. Hastings IM, Watkins WM 2005. Intensity of malaria transmission and the evolution of drug resistance. Acta Trop 94: 218-229.
62. Hastings IM, Watkins WM, White NJ 2002. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci 357: 505-519.
63. Hatabu T, Iwagami M, Kawazu S, Taguchi N, Escueta AD, Villacorte EA, Rivera PT, Kano S 2009. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: a Philippine study. Parasitol Int 58: 166-170.
64. Hatabu T, Kawazu S, Kojima S, Sato K, Singhasivanon P, Looareesuwan S, Kano S 2005. In vitro susceptibility and genetic variations for chloroquine and mefloquine in Plasmodium falciparum isolates from Thai-Myanmar border. Southeast Asian J Trop Med Public Health 36 (Suppl. 4): S73-S79.
65. Hayton K, Su X-z 2004. Genetic and biochemical aspects of drug resistance in malaria parasites. Curr Drug Targets Infect Disord 4: 1-10.
66. Hayton K, Su X-z 2008. Drug resistance and genetic mapping in Plasmodium falciparum. Curr Genet 54: 223-239.
67. Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Björkman A 2006. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr 1 86Y. Infect Genet Evol 6: 309-314.
68. Huaman MC, Yoshinaga K, Suryanatha A, Suarsana N, Kanbara H 2004. Polymorphisms in the chloroquine resistance transporter gene in Plasmodium falciparum isolates from Lombok, Indonesia. Am J Trop Med Hyg 71: 40-42.
69. Hyde JE 2005. Drug-resistant malaria. Trends Parasitol 21: 494-498.
70. Jiang H, Joy DA, Furuya T, Su X-z 2006. Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum. J Postgrad Med 52: 271-276.
71. Jiang H, Patel JJ, Yi M, Mu J, Ding J, Stephens R, Cooper RA, Ferdig MT, Su X-z 2008. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS ONE 3: e2484.
72. Juliano JJ, Kwiek JJ, Cappell K 2007. Minority-variant Pfcrt K76T mutations and chloroquine resistance, Malawi. Emerg Infect Dis 13: 873-877.
73. Kidgell C, Volkman SK, Daily J, Borevitz JO, Plouffe D, Zhou Y, Johnson JR, Le Roch K, Sarr O, Ndir O, Mboup S, Batalov S, Wirth DF, Winzeler EA 2006. A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathol 2: e57.
74. Keen J, Farcas GA, Zhong K, Yohanna S, Dunne MW, Kain KC 2007. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India. J Clin Microbiol 45: 2889-2893.
75. Klayman DL 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055.
76. Krogstad DJ 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
77. Krogstad DJ, Gluzman IY, Herwaldt BL, Schlesinger PH, Wellems TE 1992. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol 43: 57-62.
78. Krogstad DJ, Gluzman IY, Kyle DE, Oduola AM, Martin SK, Milhous WK, Schlesinger PH 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
79. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187: 1870-1875.
80. Lakshmanan V, Bray PG, Verdier-Pinard D, Johnson DJ, Horrocks P, Muhle RA, Alakpa GE, Hughes RH, Ward SA, Krogstad DJ, Sidhu ABS, Fidock DA 2005. A critical role for PfCRT K76T in Plasmodium falciparum verapamil reversible chloroquine resistance. EMBO J 24: 2294-2305.
81. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV 2006. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355: 1959-1966.
82. Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, Denis MB, Hewitt S, Hoyer S, Socheat D, Merecreau-Puijalon O, Fandeur T 2003. Pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Agents Chemother 47: 87-94.
83. Litsios S 1996. The tomorrow of malaria, Pacific Press, Wellington, 181 pp.
84. Londono BL, Eisele TP, Keating J, Bennett A, Chattopadhyay C, Heyliger G, Mack B, Rawson I, Vely JF, Désinor O, Krogstad DJ 2009. Chloroquine-resistant haplotype Plasmodium falciparum parasites, Haiti. Emerg Infect Dis 15: 735-740.
85. Lumb V, Madan R, Das MK, Rawat V, Dev V, Khan W, Khan H, Sharma YD 2012. Differential genetic hitchhiking around mutant pfcrt alleles in the Indian Plasmodium falciparum population. J Antimicrob Chemother 7: 600-608.
86. Maberti S 1960. Development of resistance to pyrimethamine. Presentation of 15 cases studied in Trujillo, Venezuela. Arch Venez Med Trop Parasitol Med 3: 239-259.
87. Mallick PK, Sutton PL, Singh R, Singh OP, Dash AP, Singh AK, Carlton JM, Bhasin VK 2013. Microsatellite analysis of chloroquine resistance associated alleles and neutral loci reveal genetic structure of Indian Plasmodium falciparum. Infect Genet Evol 19: 164-175.
88. Martin RE, Kirk K 2004. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol Biol Evol 21: 1938-1949.
89. Maughan SC, Pasternak M, Cairns N, Kiddle G, Brach T, Jarvis R, Haas F, Nieuwland J, Lim B, Müller C, Salcedo-Sora E, Kruse C, Orsel M, Hell R, Miller AJ, Bray P, Foyer CH, Murray JA, Meyer AJ, Cobbett CS 2010. Plant homologs of the Plasmodium falciparum chloroquine-resistance transporter, PfCRT, are required for glutathione homeostasis and stress responses. Proc Natl Acad Sci USA 107: 2331-2336.
90. Mbenda HGN, Das A 2013. Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum. J Antimicrob Chemother doi: 10.1093/jac/dkt388.
91. Mehlotra RK, Fujioka H, Roepe PD 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with Pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA 98: 12689-12694.
92. Mehlotra RK, Mattera G, Bockarie MJ, Maguire JD, Baird JK, Sharma YD, Alifrangis M, Dorsey G, Rosenthal PJ, Fryauff DJ, Kazura JW, Stoneking M, Zimmerman PA 2008. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 52: 2212-2222.
93. Menard D, Djalle D, Yapou F, Manirakiza A, Talarmin A 2006. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic. Am J Trop Med Hyg 74: 205-210.
94. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A 2003. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68: 413-415.
95. Mita T, Kaneko A, Lum JK, Zungu IL, Tsukahara T, Eto H, Kobayakawa T, Bjorkman A, Tanabe K 2004. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 135: 159-163.
96. Mita T, Tanabe K 2012. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis 65: 465-475.
97. Mita T, Tanabe K, Kita K 2009. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58: 201-209.
98. Mittra P, Vinayak S, Chandawat H, Das MK, Singh N, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD 2006. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J Infect Dis 193: 1304-1312.
99. Mixon-Hayden T, Jain V, McCollum AM, Poe A, Nagpal AC, Dash AP, Stiles JK, Udhayakumar V, Singh N 2010. Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India. Antimicrob Agents Chemother 54: 997-1006.
100. Moore DV, Lanier JE 1961. Observations on the two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 10: 5-9.
101. Mu J, Awadalla P, Duan J 2005. Recombination hotspots and population structure in Plasmodium falciparum. PLoS Biol 3: e335.
102. Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, Subramanian G, Aravind L, Cooper RA, Wootton JC, Xiong M, Su X-z 2003. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49: 977-989.
103. Mu J, Myers RA, Jiang H, Liu S, Ricklefs S, Waisberg M, Chotivanich K, Wilairatana P, Krudsood S, White NJ, Udomsangpetch R, Cui L, Ho M, Ou F, Li H, Song J, Li G, Wang X, Seila S, Sokunthea S, Socheat D, Sturdevant DE, Porcella SF, Fairhurst RM, Wellems TE, Awadalla P, Su X-z 2010a. Plasmodium falciparum genome wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet 42: 268-271.
104. Mu J, Seydel KB, Bates A, Su X-z 2010b. Recent progress in functional genomic research in Plasmodium falciparum. Curr Genomics 11: 279-286.
105. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A 2009. Chloroquine resistance before and after its withdrawal in Kenya. Malar J 8: 106.
106. Nagesha HS, Casey GC, Rieckmann KH, Fryauff DJ, Laksana BS, Reeder JC, Maguire JD, Baird JK 2003. New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates. Am J Trop Med Hyg 68: 398-402.
107. Ngo T, Duraisingh M, Reed M, Hipgrave D, Biggs B, Cowman AF 2003. Analysis of pfcrt, pfmdr 1, dhfr and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am J Trop Med Hyg 68: 350-356.
108. Niang M, Marrama L, Ekala MT 2008. Accumulation of CVIET Pfcrt allele of Plasmodium falciparum in placenta of pregnant women living in an urban area of Dakar, Senegal. J Antimicrob Chemother 62: 921-928.
109. Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ 2007. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrob Agents Chemother 51: 3023-3025.
110. Orjih AU, Ryerse JS, Fitch CD 1994. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Experientia 50: 34-39.
111. Pati SS, Mishra S, Mohanty S, Mohapatra DN, Sahu PK, Priyadarshi N, Kumar S, Sharma SK, Tyagi PK, Chitnis CE, Das BS 2007. Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, India. Trans R Soc Trop Med Hyg 101: 650-654.
112. Payne D 1987. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today 3: 241-246.
113. Peters W 1987. Chemotherapy and drug resistance in malaria, 2nd ed., Academic Press, London, 542 pp.
114. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P 2009. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J 8: 89.
115. Pineda ER, Arango E, do Rosário VEMA, Cravo P 2008. Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt. Parasitology 135: 547-553.
116. Plowe CV 2009. The evolution of drug-resistant malaria. Trans R Soc Trop Med Hyg 1035: 11-14.
117. Plummer WB, Pereira LMP, Carrington CVF 2004. Pfcrt and pfmdr1 alleles associated with chloroquine resistance in Plasmodium falciparum from Guyana, South America. Mem Inst Oswaldo Cruz 99: 389-392.
118. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364: 438-447.
119. Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, Fay MP, McCutchan TF, Su X-z 2009. Disruption of a Plasmodium falcipa-rum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem 284: 7687-7696.
120. Randrianarivelojosia M, Fidock DA, Belmonte O, Valderramos SG, Mercereau-Puijalon O, Ariey F 2006. First evidence of pfcrt mutant Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg 100: 826-830.
121. Rason MA, Andrianantenaina HB, Ariey F, Raveloson A, Domarle O, Randrianarivelojosia M 2007. Prevalent Pfmdr1 N86Y mutant Plasmodium falciparum in Madagascar despite absence of Pfcrt mutant strains. Am J Trop Med Hyg 76: 1079-1083.
122. Rawasia WF, Sridaran S, Patel JC, Abdallah J, Ghanchi NK, Barnwell JW, Escalante AA, Udhayakumar V, Beg MA 2012. Genetic backgrounds of the Plasmodium falciparum chloroquine resistant transporter (pfcrt) alleles in Pakistan. Infect Genet Evol 12: 278-281.
123. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403: 906-909.
124. Restrepo E, Fonseca JC, Maestre A 2008. Plasmodium falciparum: high frequency of pfcrt point mutations and emergence of new mutant haplotypes in Colombia. Biomedica 28: 523-530.
125. Reyes S 1981. Malarial infections with Plasmodium falciparum resistant to chloroquine treatment. The situation in Brazil (1960-1981). Rev Bras Malariol Doencas Trop 33: 109-130.
126. Ridley RG 2002. Medical need, scientific opportunity and the drive for anti-malarial drugs. Nature 415: 686-693.
127. Roepe PD 2009. Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria. Future Microbiol 4: 441-455.
128. Sa JM, Twu O 2010. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malar J 9: 374.
129. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE 2009. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA 106: 18883-18889.
130. Sakihama N, Ohmae H, Bakote'e B, Kawabata M, Hirayama K, Tanabe K 2006. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am J Trop Med Hyg 74: 31-40.
131. Sanchez CP, Dave A, Stein WD 2010. Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol 40: 1109-1118.
132. Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M 2005. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44: 9862-9870.
133. Sanchez CP, McLean JE, Stein W, Lanzer M 2004. Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43: 16365-16373.
134. Sanchez CP, Stein W, Lanzer M 2003. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 42: 9383-9394.
135. Schofield L, Mueller I 2006. Clinical immunity to malaria. Curr Mol Med 6: 205-221.
136. Sehgal PN, Sharma MID, Gogai S, 1973. Resistance to chloroquine in falciparum malaria in Assam state, India. J Comm Dis 5: 175-180.
137. Severini C, Menegon M, Sannella AR, Paglia MG, Narciso P, Matteelli A, Gulletta M, Caramello P, Canta F, Xayavong MV, Moura IN, Pieniazek NJ, Taramelli D, Majori G 2006. Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol 6: 262-268.
138. Sharma VP 2007. Battling the malaria iceberg with chloroquine in India. Malar J 6: 105.
139. Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine and artemisinin. J Infect Dis 194: 528-535.
140. Sidhu AB, Valderramos SG, Fidock DA 2005. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57: 913-926.
141. Sidhu AB, Verdier-Pinard D, Fidock DA 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298: 210-213.
142. Singh V, Mishra N, Awasthi G, Dash AP, Das A 2009. Why is it important to study malaria epidemiology in India? Trends Parasitol 24: 228-235.
143. Stephan W 2010. Detecting strong positive selection in the genome. Mol Ecol Resour 10: 863-872.
144. Su X-z, Kirkman LA, Fujioka H, Wellems TE 1997. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603.
145. Summers RL, Nash MN, Martin RE 2012. Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics. Cell Mol Life Sci 69: 1967-1995.
146. Sutar SKD, Gupta B, Ranjit M, Kar SK, Das A 2011. Sequence ana-lysis of coding DNA fragments of pfcrt and pfmdr-1 genes in Plasmodium falciparum isolates from Odisha, India. Mem Inst Oswaldo Cruz 106: 78-84.
147. Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, Sattabongkot J, Nakamura M, Sakurai M, Kobayashi J, Kaneko A, Endo H, Hombhanje F, Tsuboi T, Mita T 2012. Large scale survey of novel genotypes of Plasmodium falciparum chloroquine resistance gene Pfcrt. Malar J 11: 92.
148. Talisuna AO, Bloland P, D'Alessandro U 2004. History, dynamics and public health importance of malaria parasite resistance. Clin Microbiol Rev 17: 235-254.
149. Talisuna AO, Langi P, Mutabingwa TK, Van Marck E, Speybroeck N, Egwang TG, Watkins WW, Hastings IM, D'Alessandro U 2003. Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria. Int J Parasitol 33: 1051-1058.
150. Talisuna AO, Okello PE, Erhart A, Coosemans M, D'Alessandro U 2007. Intensity of malaria transmission and the spread of Plasmodium falciparum-resistant malaria: a review of epidemiologic field evidence. Am J Trop Med Hyg 77: 170-180.
151. Tanabe K, Sakihama N, Kaneko A 2004. Stable SNPs in malaria antigen genes in isolated populations. Science 303: 493
152. Tatem AJ, Smith DL 2010. International population movements and regional Plasmodium falciparum malaria elimination strategies. Proc Natl Acad Sci USA 107: 12222-12227.
153. Telgt DS, van der Ven AJ, Schimmer B, Droogleever-Fortuyn HA, Sauerwein RW 2005. Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection. Ann Pharmacother 39: 551-554.
154. Thompson PE, Werbel LM 1972. Antimalarial agents: chemistry and pharmacology, Academic Press Inc, New York, 395 pp.
155. Valderramos SG, Fidock DA 2006. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci 27: 594-601.
156. Valderramos SG, Valderramos JC, Musset L, Purcell LA, Mercereau-Puijalon O, Legrand E, Fidock DA 2010. Identification of a mutant Pfcrt-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog 6: e1000887.
157. Vathsala PG, Pramanik A, Dhanasekaran S, Devi CU, Pillai CR, Subbarao SK, Ghosh SK, Tiwari SN, Sathyanarayan TS, Deshpande PR, Mishra GC, Ranjit MR, Dash AP, Rangarajan PN, Padmanaban G 2004. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg 70: 256-259.
158. Vieira PP, Ferreira MU, Alecrim MDAC, Alecrim WD, da Silva LH, Sihuincha MM, Joy DA, Mu J, Su X-z, Zalis MG 2004. Pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon basin. J Infect Dis 190: 417-424.
159. Vinayak S, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD 2003. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Trop 87: 287-293.
160. Vinayak S, Mittra P, Sharma YD 2006. Wide variation in microsatellite sequences within each Pfcrt mutant haplotype. Mol Biochem Parasitol 147: 101-108.
161. Volkman SK, Neafsey DE, Schaffner SF, Park DJ, Wirth DF 2012. Harnessing genomics and genome biology to understand malaria biology. Nat Rev Genet 13: 315-328.
162. Volkman SK, Sabeti PC, DeCaprio D, Neafsey DE, Schaffner SF, Milner Jr DA, Daily JP, Sarr O, Ndiaye D, Ndir O, Mboup S, Duraisingh MT, Lukens A, Derr A, Stange-Thomann N, Waggoner S, Onofrio R, Ziaugra L, Mauceli E, Gnerre S, Jaffe DB, Zainoun J, Wiegand RC, Birren BW, Hartl DL, Galagan JE, Lander ES, Wirth DF 2007. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 39: 113-119.
163. Walliker D, Hunt P, Babiker H 2005. Fitness of drug-resistant malaria parasites. Acta Trop 94: 251-259.
164. Wang X, Mu J, Li G, Chen P, Guo X, Fu L, Chen L, Su X, Wellems TE 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am J Trop Med Hyg 72: 410-414.
165. Wellems T, Walker-Jonah A, Panton LJ 1991. Genetic mapping of the chloroquine resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA 88: 3382-3386.
166. Wellems TE 2002. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Science 298: 124-126.
167. Wellems TE, Hayton K, Fairhurst RM 2009. The impact of malaria parasitism: from corpuscles to communities. J Clin Invest 119: 2496-2505.
168. Wellems TE, Plowe CV 2001. Chloroquine resistant malaria. J Infect Dis 184: 770-776.
169. Wernsdorfer WH 1994. Epidemiology of drug resistance in malaria. Acta Trop 56: 143-156.
170. Wernsdorfer WH, Payne D 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50: 95-121.
171. White NJ 2004. Antimalarial drug resistance. J Clin Invest 113: 1084-1092.
172. WHO-World Health Organization 1973. Chemotherapy of malaria and resistance to antimalarials: report of a WHO scientific group. WHO Tech Rep Ser 529: 1-121.
173. WHO-World Health Organization 1984. Advances in malaria chemotherapy. WHO Tech Rep Ser 711: 1-218.
174. WHO-World Health Organization 2002. Southern Africa Malaria Control Programme. WHO/CDS/RBM/2002.42.
175. WHO-World Health Organization 2011. World malaria report 2011, WHO Global Malaria Programme. WHO, Geneva, 278 pp.
176. Wongsrichanalai C, Pickard AL, Wernsdorfer WH 2002. Epidemiology of drug resistant malaria. Lancet Infect Dis 2: 209-218.
177. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su X-z 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323.
178. Yang Z, Zhang Z, Sun X 2007. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop Med Int Health 12: 1051-1060.
179. Young MD, Moore DV 1961. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg 10: 317-320.
180. Zakeri S, Afsharpad M, Kazemzadeh T, Mehdizadeh K, Shabani A, Djadid ND 2008. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Am J Trop Med Hyg 78: 633-640.
181. Zhang JJ, Senaratne TN, Daniels R, Valim C, Alifrangis M, Amerasinghe P, Konradsen F, Rajakaruna R, Wirth DF, Karunaweera ND 2011. Distribution pattern of Plasmodium falciparum chloroquine transporter (pfcrt) gene haplotypes in Sri Lanka 1996-2006. Am J Trop Med Hyg 85: 811.